Track topics on Twitter Track topics that are important to you
Abilify (Aripiprazole) is an atypical antipsychotic produced by <!--LGfEGNT2Lhm-->Bristol-Myers Squibb Company, with annual sales of $3m, ranking it 6th in the world for annual sales.
Abilify is prescribed in addition to other anti-depressants for the treatment of <!--LGfEGNT2Lhm-->depression, and additionally for <!--LGfEGNT2Lhm-->bipolar disorder and schizophrenia. The FDA has recently licensed it for use in treating irritability associated with Autistic Disorder in pediatric patients (ages 6 to 17), as part of a total treatment plan.
Source; Adapted from Bioportfolio.com and Abilify.com
Add the Abilify News Channel to your RSS reader;
Follow the Abilify Twitter feed;